FDAsafety guidance72% confidence
Positive Pressure Breathing Device Correction: Baxter Issues Correction for Volera Positive Pressure Breathing Devices
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (ild) as asthma treatment guidelines.
Regulatory Analysis
Volara system patient circuits may leak air and medication from the nebulizer cup during therapy, leading to reduced oxygenation and ineffective nebulization.
Supporting Context
- Therapeutic area
- Respiratory · Asthma
- Sub-indication
- Ild
Related signal: Study on Buteyko Breathing Technique's Impact on Childhood Asthma Control